This content is in French.
The silent face of autoimmune liver diseases
31 juillet 2025
By Ana Espino | Published on July 31, 2025 | 3 min read
#Hepatitis #Immunity #Autoimmunity #HepaticFibrosis
Hepatic fibrosis is a common, progressive, and often silent complication of autoimmune liver diseases (AILD), including primary biliary cholangitis (PBC), autoimmune hepatitis (AIH), and primary sclerosing cholangitis (PSC). These conditions are characterized by chronic inflammation that causes liver damage, which progresses to fibrosis and eventually cirrhosis in the absence of effective treatment.
#Hepatitis #Immunity #Autoimmunity #HepaticFibrosis
Hepatic fibrosis is a common, progressive, and often silent complication of autoimmune liver diseases (AILD), including primary biliary cholangitis (PBC), autoimmune hepatitis (AIH), and primary sclerosing cholangitis (PSC). These conditions are characterized by chronic inflammation that causes liver damage, which progresses to fibrosis and eventually cirrhosis in the absence of effective treatment.
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
Lytvyak, E., et al. (2025). Pathogenesis, Non-Invasive Assessments and Treatment of Hepatic Fibrosis in Autoimmune Liver Diseases. Liver international : official journal of the International Association for the Study of the Liver, 45(8), e70190
View the source
